{"id":"recombinant-gonadotropins","safety":{"commonSideEffects":[{"rate":"1-14","effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Abdominal pain or bloating"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL1201718","moleculeType":"Enzyme"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Recombinant gonadotropins mimic naturally occurring follicle-stimulating hormone (FSH) and/or luteinizing hormone (LH) to promote gametogenesis. In females, they stimulate follicle development and ovulation; in males, they promote spermatogenesis. These are produced through recombinant DNA technology rather than extracted from biological sources.","oneSentence":"Recombinant gonadotropins are hormones that stimulate the ovaries or testes to produce eggs or sperm for reproductive purposes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:04:02.974Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Female infertility due to anovulation or low ovarian reserve (assisted reproductive technology)"},{"name":"Male infertility due to hypogonadotropic hypogonadism or low sperm production"}]},"trialDetails":[{"nctId":"NCT06378268","phase":"NA","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-24","conditions":"Progestins Primed Ovarian Stimulation","enrollment":626},{"nctId":"NCT04983173","phase":"PHASE4","title":"INTEnsity of ovariaN Stimulation and Embryo Quality","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-11-23","conditions":"Infertility","enrollment":110},{"nctId":"NCT02871167","phase":"NA","title":"Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2016-12","conditions":"Breast Cancer","enrollment":140},{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT07425990","phase":"NA","title":"FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles","status":"NOT_YET_RECRUITING","sponsor":"University of Novi Sad","startDate":"2026-02","conditions":"Infertility Female, Frozen Embryo Transfer (FET)","enrollment":120},{"nctId":"NCT07348757","phase":"","title":"rFSH vs rFSH+rLH in Dydrogesterone-Based Progestin Protocol: A Prospective Study","status":"RECRUITING","sponsor":"Centrum Clinic IVF Center","startDate":"2026-01-05","conditions":"InVitro Fertilization, Gonadotropins","enrollment":300},{"nctId":"NCT06440850","phase":"PHASE2","title":"Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-15","conditions":"Thyroid Gland Follicular Carcinoma, Thyroid Gland Oncocytic Carcinoma, Thyroid Gland Papillary Carcinoma","enrollment":21},{"nctId":"NCT07346235","phase":"PHASE3","title":"150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial","status":"NOT_YET_RECRUITING","sponsor":"American Hospital 2 Kosovo","startDate":"2026-03-01","conditions":"Infertility, Female","enrollment":440},{"nctId":"NCT05296798","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-07-18","conditions":"Locally Advanced or Metastatic Breast Cancer","enrollment":922},{"nctId":"NCT07269392","phase":"PHASE4","title":"Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2026-01-01","conditions":"In Vitro Fertilization (IVF), Embryo Transfer","enrollment":170},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT04037605","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2020-02-09","conditions":"Sleep Restriction","enrollment":5},{"nctId":"NCT03142893","phase":"PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peter y. Liu","startDate":"2017-05-08","conditions":"Sleep Restriction","enrollment":80},{"nctId":"NCT04710264","phase":"","title":"Aurora Test for Patients Treated With Recombinant Gonadotropins","status":"COMPLETED","sponsor":"Fertiga, Belgium","startDate":"2021-02-15","conditions":"Infertility","enrollment":137},{"nctId":"NCT07128394","phase":"NA","title":"Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment","status":"RECRUITING","sponsor":"Nanjing University","startDate":"2024-02-01","conditions":"Infertility, Female, Luteinizing Hormone (LH)","enrollment":590},{"nctId":"NCT07121751","phase":"PHASE4","title":"Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)","status":"NOT_YET_RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-09-01","conditions":"Hypo-responder, Infertility (IVF Patients), OVARIAN STIMULATION","enrollment":150},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":"OVARIAN STIMULATION, Telomere Length, Telomere Length, Mean Leukocyte","enrollment":10},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT06966219","phase":"","title":"Trigger Protocol on the Rate of Pregnancy After Intracytoplasmic Sperm Injection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez University","startDate":"2025-05-01","conditions":"Infertility","enrollment":90},{"nctId":"NCT06883890","phase":"PHASE2","title":"Extended LH Administration","status":"NOT_YET_RECRUITING","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2025-03-17","conditions":"Ovarian Reserve","enrollment":84},{"nctId":"NCT02496754","phase":"NA","title":"Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2016-06","conditions":"Clinical Pregnancy Rate, Ovulation Induction, IVF","enrollment":1266},{"nctId":"NCT06763926","phase":"PHASE4","title":"Intranasal Nafarelin For Triggering Oocyte Maturation","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Dexeus","startDate":"2025-03-15","conditions":"Fertility Disorders","enrollment":134},{"nctId":"NCT06572930","phase":"","title":"Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2024-12-16","conditions":"Ovarian Stimulation","enrollment":150},{"nctId":"NCT06778733","phase":"EARLY_PHASE1","title":"Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders","status":"COMPLETED","sponsor":"University of Athens","startDate":"2022-01-01","conditions":"Female Infertility","enrollment":22},{"nctId":"NCT04064840","phase":"PHASE3","title":"GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2019-09-01","conditions":"Subfertility","enrollment":784},{"nctId":"NCT06414096","phase":"PHASE1","title":"Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-10-01","conditions":"Infertility, Obesity","enrollment":5},{"nctId":"NCT03741699","phase":"PHASE3","title":"Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH)","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI Alicante","startDate":"2019-02-18","conditions":"Infertility, Female","enrollment":88},{"nctId":"NCT00702338","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05-15","conditions":"Pregnancy, Neonates","enrollment":1},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT00702234","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-15","conditions":"Pregnancy, Neonates","enrollment":268},{"nctId":"NCT06571214","phase":"PHASE4","title":"Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment","status":"NOT_YET_RECRUITING","sponsor":"Nanjing University","startDate":"2024-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT06561594","phase":"PHASE3","title":"To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-09-20","conditions":"Idiopathic Hypogonadotropic Hypogonadism","enrollment":60},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":"Infertility","enrollment":397},{"nctId":"NCT00696878","phase":"PHASE3","title":"Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09-26","conditions":"In Vitro Fertilization","enrollment":682},{"nctId":"NCT00697255","phase":"PHASE2","title":"A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-15","conditions":"Ovulation Induction","enrollment":8},{"nctId":"NCT04719000","phase":"PHASE4","title":"PErsonalized Addition of Recombinant LH in Ovarian Stimulation","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-02-04","conditions":"Infertility","enrollment":120},{"nctId":"NCT03846544","phase":"PHASE4","title":"Double Pick up in Poor Prognosis Women","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2019-10-01","conditions":"Fertility Disorders","enrollment":48},{"nctId":"NCT06413771","phase":"NA","title":"Only Gonadotropin Vs. Letrozole Combined Gonadotropin Stimulation in IUI Cycles","status":"COMPLETED","sponsor":"Uludag University","startDate":"2023-01-01","conditions":"Infertility Unexplained","enrollment":131},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT05405686","phase":"PHASE4","title":"Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders","status":"WITHDRAWN","sponsor":"CRG UZ Brussel","startDate":"2023-05-01","conditions":"Poor Response to Ovulation Induction","enrollment":""},{"nctId":"NCT05670795","phase":"NA","title":"Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles","status":"UNKNOWN","sponsor":"Bezmialem Vakif University","startDate":"2023-01-01","conditions":"Infertility Unexplained","enrollment":254},{"nctId":"NCT03738618","phase":"PHASE3","title":"Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-10-29","conditions":"Infertility, Female","enrollment":588},{"nctId":"NCT03740737","phase":"PHASE3","title":"Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-10-26","conditions":"Infertility","enrollment":579},{"nctId":"NCT06199960","phase":"PHASE3","title":"Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2019-08-02","conditions":"Assisted Reproductive Techniques","enrollment":116},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":"Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility","enrollment":30},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04447872","phase":"NA","title":"The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2020-09-15","conditions":"Infertility, Diminished Ovarian Reserve, IVF","enrollment":142},{"nctId":"NCT02554279","phase":"PHASE4","title":"MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-08-31","conditions":"Infertility","enrollment":620},{"nctId":"NCT03495609","phase":"PHASE4","title":"Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2016-02-17","conditions":"hCG, BRCA1 Mutation, BRCA2 Mutation","enrollment":33},{"nctId":"NCT03564509","phase":"PHASE2","title":"A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-05-14","conditions":"Controlled Ovarian Stimulation","enrollment":620},{"nctId":"NCT04992468","phase":"PHASE4","title":"Dual Trigger for Elective Fertility Preservation","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-10-05","conditions":"Infertility","enrollment":136},{"nctId":"NCT04189133","phase":"PHASE2","title":"Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2022-01-19","conditions":"Acquired Hypogonadotropic Hypogonadism","enrollment":32},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":"Infertility","enrollment":120},{"nctId":"NCT05602090","phase":"PHASE2, PHASE3","title":"Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2022-02-01","conditions":"Poor Ovarian Reserve","enrollment":120},{"nctId":"NCT05778331","phase":"","title":"The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-10","conditions":"Infertility, Female, IVF","enrollment":340},{"nctId":"NCT05571111","phase":"PHASE2","title":"Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation","status":"WITHDRAWN","sponsor":"Ferring Pharmaceuticals","startDate":"2022-10-04","conditions":"Infertility","enrollment":""},{"nctId":"NCT04193930","phase":"NA","title":"Different Protocols in Ovarian Stimulation in Intracytoplasmic Sperm Injection Cycles","status":"WITHDRAWN","sponsor":"Assiut University","startDate":"2021-01-01","conditions":"ART","enrollment":""},{"nctId":"NCT05370794","phase":"","title":"Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-04-19","conditions":"In Vitro Maturation of Oocytes","enrollment":35},{"nctId":"NCT05110391","phase":"","title":"Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy","status":"COMPLETED","sponsor":"ANDROFERT - Clinica de Andrologia e Reproducao Humana","startDate":"2014-02-01","conditions":"Non-obstructive Azoospermia, Hormone Deficiency, Hypogonadism, Male","enrollment":616},{"nctId":"NCT02402192","phase":"PHASE4","title":"Type of Gonadotropin and Embryo Kinetics of Development","status":"TERMINATED","sponsor":"IVI Madrid","startDate":"2015-04","conditions":"Infertility","enrollment":201},{"nctId":"NCT04899193","phase":"PHASE1","title":"Pergoveris FD and Liquid China BE Study","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2021-05-08","conditions":"Healthy","enrollment":72},{"nctId":"NCT02149277","phase":"PHASE3","title":"Gcsf Injection in Women With Repeated Implantaiton Failure","status":"TERMINATED","sponsor":"Clinique Ovo","startDate":"2013-03","conditions":"Repeated Embryo Implantation Failure","enrollment":15},{"nctId":"NCT00920634","phase":"","title":"Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-07","conditions":"Anovulation","enrollment":384},{"nctId":"NCT01599494","phase":"PHASE3","title":"An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2014-03","conditions":"Infertility","enrollment":""},{"nctId":"NCT00702624","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-04","conditions":"Pregnancy, Neonates","enrollment":113},{"nctId":"NCT00724789","phase":"","title":"Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-11","conditions":"Pregnancy, Neonates","enrollment":2066},{"nctId":"NCT00702546","phase":"","title":"Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"In Vitro Fertilization","enrollment":102},{"nctId":"NCT05220995","phase":"","title":"The Effects of Miminal Stimulation Protocol on Preimplantation Genetic Screening","status":"UNKNOWN","sponsor":"Gokalp Oner","startDate":"2021-05-15","conditions":"Preimplantation Genetic Screening","enrollment":200},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT03252223","phase":"PHASE4","title":"Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2017-10-02","conditions":"Polycystic Ovary Syndrome, Healthy, Anovulation","enrollment":33},{"nctId":"NCT01297465","phase":"PHASE3","title":"PERgoveriS In Stratified Treatment for Assisted Reproductive Technique","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2011-05-31","conditions":"Assisted Reproductive Techniques, Reproductive Technology, Assisted","enrollment":202},{"nctId":"NCT01477073","phase":"PHASE1","title":"Multiple Dose FSH-GEX(TM) in Healthy Volunteers","status":"COMPLETED","sponsor":"Glycotope GmbH","startDate":"2011-10","conditions":"Female Infertility","enrollment":57},{"nctId":"NCT03876145","phase":"NA","title":"The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2016-11-12","conditions":"Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome","enrollment":120},{"nctId":"NCT03423537","phase":"PHASE3","title":"Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART","status":"TERMINATED","sponsor":"National and Kapodistrian University of Athens","startDate":"2018-06-01","conditions":"HCG; IVF; Pregnancy Rates; ART; Chorionic Gonadotropin","enrollment":80},{"nctId":"NCT01319695","phase":"PHASE1, PHASE2","title":"Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2011-01","conditions":"Infertility","enrollment":140},{"nctId":"NCT03735030","phase":"PHASE1","title":"Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2018-11-27","conditions":"Infertility","enrollment":26},{"nctId":"NCT04717752","phase":"NA","title":"A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve","status":"UNKNOWN","sponsor":"Nanjing University","startDate":"2021-01-20","conditions":"Poor Ovarian Response","enrollment":310},{"nctId":"NCT00700778","phase":"NA","title":"Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations","status":"TERMINATED","sponsor":"Fox Chase Cancer Center","startDate":"2008-07","conditions":"BRCA1 Mutation, Breast Cancer","enrollment":2},{"nctId":"NCT04325295","phase":"NA","title":"LOD vs Gn in Anovulatory PCOs Resistant to First Line Agents","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-12","conditions":"Polycystic Ovary Syndrome, Anovulation","enrollment":200},{"nctId":"NCT03356964","phase":"EARLY_PHASE1","title":"Step Down FSH Approach and Late Follicular Phase in Progesterone Level","status":"COMPLETED","sponsor":"ART Fertility Clinics LLC","startDate":"2017-11-23","conditions":"Progesterone Resistance","enrollment":127},{"nctId":"NCT04539613","phase":"","title":"Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle","status":"UNKNOWN","sponsor":"Alaa Fouli Gaber Ebrahim","startDate":"2020-09-01","conditions":"Ovarian Stimulation in ICSI","enrollment":100},{"nctId":"NCT04522479","phase":"NA","title":"Prolonged Protocol of Early Follicular or Mid Luteal Phase","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2020-05-13","conditions":"IVF","enrollment":1150},{"nctId":"NCT02418533","phase":"NA","title":"Mono-menotropins Versus rFSH Protocol on Embryo Quality","status":"COMPLETED","sponsor":"Main Line Fertility Center","startDate":"2015-03","conditions":"Infertility, Fertility","enrollment":109},{"nctId":"NCT04458454","phase":"","title":"\"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles\"","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2019-12-02","conditions":"Infertility, Reproductive Techniques, Assisted, Oocyte Maturation","enrollment":11},{"nctId":"NCT04361292","phase":"NA","title":"Ejaculatory Abstinence in IUI Cycles","status":"COMPLETED","sponsor":"Pamukkale University","startDate":"2019-01-01","conditions":"Infertility, Spermatozoa, Reproductive Disorder","enrollment":120},{"nctId":"NCT03134482","phase":"NA","title":"Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS","status":"UNKNOWN","sponsor":"CHA University","startDate":"2017-05-01","conditions":"No Condition","enrollment":240},{"nctId":"NCT02179255","phase":"PHASE1, PHASE2","title":"Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF","status":"UNKNOWN","sponsor":"Center for Human Reproduction","startDate":"2014-08-01","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":30},{"nctId":"NCT04134130","phase":"NA","title":"The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer","status":"COMPLETED","sponsor":"Lund University","startDate":"2019-09-16","conditions":"Prostate Cancer Recurrent","enrollment":33},{"nctId":"NCT03463772","phase":"NA","title":"IVM Versus Standard IVF in Infertile Patients Diagnosed With PCOS","status":"UNKNOWN","sponsor":"Jie Qiao","startDate":"2018-03-16","conditions":"PCOS","enrollment":350},{"nctId":"NCT04122729","phase":"","title":"N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS","status":"UNKNOWN","sponsor":"Angelini Farmacéutica","startDate":"2019-09-25","conditions":"In Vitro Fertilization, Controlled Ovarian Stimulation","enrollment":300},{"nctId":"NCT01969201","phase":"PHASE4","title":"FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2014-01","conditions":"Infertility","enrollment":710},{"nctId":"NCT02919800","phase":"PHASE1","title":"A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2017-01-22","conditions":"Hemophilia A or B With Inhibitors","enrollment":32},{"nctId":"NCT04008966","phase":"PHASE4","title":"Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-07-20","conditions":"Assisted Reproduction","enrollment":160},{"nctId":"NCT02449889","phase":"PHASE3","title":"A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-04","conditions":"Infertility","enrollment":176},{"nctId":"NCT01154192","phase":"PHASE3","title":"Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2011-08","conditions":"PCOS","enrollment":24}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"HYPERCOAGULATION"}],"_approvalHistory":[],"publicationCount":99,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Pergoveris & Luveris","Puregon, NV Organon, Oss, The Netherlands"],"phase":"marketed","status":"active","brandName":"recombinant gonadotropins","genericName":"recombinant gonadotropins","companyName":"Sheba Medical Center","companyId":"sheba-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Recombinant gonadotropins, specifically recombinant human Follicle-Stimulating Hormone (r-FSH-alfa), are used to treat conditions such as female infertility, embryonic development, and pregnancy. They work by stimulating the ovaries to produce eggs, and are often used in combination with other medications like clomiphene citrate.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}